Allarity Therapeutics, Inc.'s market cap is currently ―. The company's EPS TTM is $-4117.544; its P/E ratio is 0.00; Allarity Therapeutics, Inc. is scheduled to report earnings on May 24, 2024, and the estimated EPS forecast is $-10.60. See an overview of income statement, balance sheet, and cash flow financials.

	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22
Income Statement	-
Total Revenue	-	-	-	$ -874.00K	$ 0.00
Gross Profit	-	-	-	$ -874.00K	-
EBIT	$ -9.35M	$ -2.24M	$ 3.76M	$ 1.83M	$ -5.00M
EBITDA	$ -9.34M	$ -2.23M	$ 3.77M	$ 1.41M	$ -4.99M
Net Income Common Stockholders	$ -5.55M	$ -9.79M	$ 3.74M	$ 7.45M	$ -6.68M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 1.40M	$ 420.00K	$ 295.00K	$ 2.03M	$ 3.95M
Total Assets	$ 13.88M	$ 13.43M	$ 12.70M	$ 14.54M	$ 18.13M
Total Debt	$ 1.17M	$ 1.49M	$ 3.80M	$ 2.65M	$ 1.09M
Net Debt	$ -232.00K	$ 1.07M	$ 3.50M	$ 623.00K	$ -2.86M
Total Liabilities	$ 17.25M	$ 14.15M	$ 13.04M	$ 12.65M	$ 14.63M
Stockholders Equity	$ -3.38M	$ -723.00K	$ -3.10M	$ -113.00K	$ 3.50M
Cash Flow	-
Free Cash Flow	$ -5.38M	$ -2.50M	$ -3.20M	$ -1.66M	$ -4.41M
Operating Cash Flow	$ -5.38M	$ -2.50M	$ -3.20M	$ -2.45M	$ -4.41M
Investing Cash Flow	-	-	-	$ -18.00K	$ 0.00
Financing Cash Flow	$ 6.45M	$ 2.87M	$ 1.16M	$ 1.00M	$ 0.00

Currency in USD

Allarity Therapeutics, Inc. Earnings and Revenue History

Income Statement >

Allarity Therapeutics, Inc. Debt to Assets

Balance Sheet >

Allarity Therapeutics, Inc. Cash Flow

Cash Flow >

Allarity Therapeutics, Inc. Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing